COVID-19 in Alzheimer’s Disease and Dementia

COVID-19 in Alzheimer’s Disease and Dementia crucially summarizes the current status of the coronavirus in patients suffering from these conditions, describing why they are a common cause of morbidity among those with COVID-19. The first section includes chapters that provide a general description of COVID-19, including SARS-CoV-2 structure, function, and biology, and its impact on the elderly with chronic conditions include hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases. Also discussed are effects of the virus on the immune system. The second section shifts to the impact of COVID-19 on those with dementia or Alzheimer’s disease, with special emphasis on age, gender, ethnic background, and lifestyle. Bringing this focus on neurodegenerative disease in one comprehensive resource, this volume is an essential reference for neuroscientists, clinicians, biomedical scientists, and all others working or interested in the field.

COVID-19 in Alzheimer’s Disease and Dementia is an important resource for anyone interested in understanding the impact of the novel coronavirus on individuals suffering from neurodegenerative diseases such as dementia and Alzheimer’s disease. In this comprehensive volume, the authors provide a thorough overview of COVID-19 and its effect on the elderly with chronic conditions before delving into the specific impact of the virus on those with dementia or Alzheimer’s disease.

The first section of the book offers readers a detailed explanation of COVID-19, including information on the virus’s structure, function, and biology. The authors also describe how COVID-19 impacts the immune system and affects individuals with chronic conditions such as hypertension, diabetes, obesity, and respiratory illnesses. They also discuss how these factors can contribute to increased morbidity among those with COVID-19.

The second section of the book focuses specifically on the impact of COVID-19 on individuals with dementia or Alzheimer’s disease. The authors discuss how age, gender, ethnic background, and lifestyle may affect an individual’s susceptibility to the virus. They also provide practical advice on how to manage the care of individuals with dementia or Alzheimer’s disease in the midst of the COVID-19 pandemic.

Overall, COVID-19 in Alzheimer’s Disease and Dementia is an invaluable resource for neuroscientists, clinicians, biomedical scientists, and anyone who is interested in understanding the impact of COVID-19 on individuals with neurodegenerative diseases. The book provides readers with a thorough understanding of the virus’s impact on the elderly with chronic conditions and offers practical advice for managing the care of individuals with dementia or Alzheimer’s disease during the pandemic.

If you are interested in learning more about COVID-19 and its impact on individuals with neurodegenerative diseases, COVID-19 in Alzheimer’s Disease and Dementia is the book for you. This essential reference is available now from Academic Press, and is the perfect resource for anyone who wants to stay informed about the latest developments in the field.

Order your copy today and stay up-to-date with the latest research and information on COVID-19 and its impact on individuals with dementia or Alzheimer’s disease. Whether you are a healthcare professional, caregiver, or simply someone who wants to learn more about this important topic, this book is a must-read. So why wait? Order your copy today and start exploring the impact of COVID-19 on individuals with neurodegenerative diseases.

Product Details

• Publisher ‏ : ‎ Academic Press; 1st edition (May 13, 2023)
• Language ‏ : ‎ English
• ‏ : ‎ 350 pages
• ISBN-10 ‏ : ‎ 044315256X
• ISBN-13 ‏ : ‎ 978-0443152566